Statements (68)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Tu_Youyou
|
| gptkbp:appointed_by |
supportive care
intravenous route oral route |
| gptkbp:associated_with |
reduced malaria transmission
|
| gptkbp:can_be_used_with |
non-artemisinin drugs
|
| gptkbp:collaborated_with |
gptkb:lumefantrine
gptkb:mefloquine gptkb:piperaquine |
| gptkbp:developed_by |
gptkb:artemisinin
gptkb:physicist gptkb:China gptkb:sweet_wormwood |
| gptkbp:first_introduced |
1970s
|
| gptkbp:has_impact_on |
malaria control
|
| https://www.w3.org/2000/01/rdf-schema#label |
artemisinin-based therapies
|
| gptkbp:includes |
gptkb:artemether
gptkb:artesunate gptkb:dihydroartemisinin |
| gptkbp:influenced_by |
climate change
|
| gptkbp:is_associated_with |
improved patient compliance
|
| gptkbp:is_challenged_by |
drug resistance
|
| gptkbp:is_considered_as |
first-line treatment
|
| gptkbp:is_effective_against |
gptkb:Person
gptkb:Plasmodium_falciparum gptkb:Plasmodium_vivax adults |
| gptkbp:is_enhanced_by |
severe malaria
|
| gptkbp:is_evaluated_by |
field studies
clinical research cost-effectiveness |
| gptkbp:is_informed_by |
epidemiological studies
|
| gptkbp:is_linked_to |
improved health outcomes
reduced mortality rates reduction in malaria cases |
| gptkbp:is_monitored_by |
drug resistance
|
| gptkbp:is_part_of |
global health initiatives
treatment protocols treatment regimens malaria treatment guidelines |
| gptkbp:is_promoted_by |
healthcare providers
public health campaigns international health organizations |
| gptkbp:is_studied_in |
efficacy
safety profile |
| gptkbp:is_subject_to |
gptkb:municipality
regulatory approval |
| gptkbp:is_supported_by |
non-profit organizations
clinical trials |
| gptkbp:is_used_for |
malaria prevention
treating malaria |
| gptkbp:is_used_in |
tropical regions
endemic regions |
| gptkbp:part_of |
combination therapy
|
| gptkbp:pests |
malaria patients
|
| gptkbp:receives_funding_from |
government agencies
|
| gptkbp:requires |
proper dosing
diagnosis of malaria |
| gptkbp:side_effect |
dizziness
headache nausea vomiting |
| gptkbp:suitable_for |
gptkb:World_Health_Organization
severe liver disease patients pregnant women in first trimester uncomplicated malaria |